Trials / Completed
CompletedNCT00447941
Safety, PK and PD Study in Healthy Male Japanese Subjects
Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Sca-136 Administered Orally to Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study assessing pharmacokinetics, pharmacodynamics, safety, and tolerability of oral doses of SCA-136 in healthy male Japanese subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCA-136 |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-08-01
- Completion
- 2006-08-01
- First posted
- 2007-03-15
- Last updated
- 2009-08-07
Source: ClinicalTrials.gov record NCT00447941. Inclusion in this directory is not an endorsement.